Recruiting Pulmonary Embolism Studies in Los Angeles
About Pulmonary Embolism Clinical Trials in Los Angeles
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 82 pulmonary embolism clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 57,340 participants. Research is being sponsored by Société Internationale d'Urologie, Regeneron Pharmaceuticals, Brigham and Women's Hospital and 63 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Los Angeles — FAQ
Are there pulmonary embolism clinical trials in Los Angeles?
Yes, there are 82 pulmonary embolism clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 82 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated October 19, 2026 from ClinicalTrials.gov